| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18572078 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 109 journal articles in the PubMed database | Email to a friend | | |
| Comi G, Pulizzi A, Rovaris M, et al.
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. [Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Lancet 2008 Jun 21; 371(9630):2085-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Polman C, Barkhof F, Sandberg-Wollheim M, et al.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Neurology 2005 Mar 22; 64(6):987-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Scott LJ, Figgitt DP
Mitoxantrone: a review of its use in multiple sclerosis. [Journal Article, Review]
CNS Drugs 2004; 18(6):379-96.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Filippi M, Wolinsky JS, Comi G
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Lancet Neurol 2006 Mar; 5(3):213-20.
Abstract | Full Citation | Find Related Articles | | Comi G, Filippi M, Wolinsky JS
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Ann Neurol 2001 Mar; 49(3):290-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bech E, Lycke J, Gadeberg P, et al.
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial]
Neurology 2002 Jan 8; 58(1):31-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | O'Connor PW, Li D, Freedman MS, et al.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. [Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial]
Neurology 2006 Mar 28; 66(6):894-900.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Segal BM, Constantinescu CS, Raychaudhuri A, et al.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. [JOURNAL ARTICLE]
Lancet Neurol 2008 Sep; 7(9):796-804.
Abstract | Full Citation | | Kappos L, Antel J, Comi G, et al.
Oral fingolimod (FTY720) for relapsing multiple sclerosis. [Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2006 Sep 14; 355(11):1124-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
New! 